Thursday - December 26, 2024

Induced Pluripotent Cell-Derived Oligodendrocyte Progenitor Cells for the Treatment of Myelin Disorders

2024-10-29

ALEXANDRIA, Virginia, Oct. 29 -- UNIVERSITY OF ROCHESTER, Rochester, New York has been assigned a patent (No. US 12129484 B2, initially filed Oct. 21, 2019) developed by Steven A. Goldman, Webster, New York, and Su Wang, Rochester, New York, for "Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disorders." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Induced Pluripotent Cell-Derived Oligodendrocyte Progenitor Cells for the Treatment of Myelin Disorders

Information Request Form

Copyright Targeted News Service 2024